New GBM Site: North Shore

❗NEW CLINICAL TRIAL SITE NOW ENROLLING PATIENTS: ReSPECT-GBM at North Shore University Hospital❗

We are excited to announce a new clinical trial investigation site for the ReSPECT-GBM clinical trial: North Shore University Hospital @NorthwellHealth in New York. Under the leadership of Principal Investigator Michael Schulder, M.D., this site is NOW ENROLLING patients in the trial aimed at improving treatment outcomes for glioblastoma (GBM), one of the most aggressive forms of brain cancer.

Meet Dr. Michael Schulder – Leading Expert in Neurosurgery and Brain Tumors

Dr. Michael Schulder, Professor and Vice Chair of the Department of Neurosurgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, brings his extensive expertise to the ReSPECT-GBM clinical trial. In addition to his role as Program Director of Neurosurgical Residency training, Dr. Schulder is a leading figure at the Feinstein Institutes for Medical Research at Northwell Health, where he also serves as a professor in the Institute of Molecular Medicine. He is the Director of the Brain Tumor Center at the Northwell Neuroscience Institute, where he works on advancing treatments for glioblastoma and other brain tumors.

Why ReSPECT-GBM Matters

The ReSPECT-GBM trial offers a promising approach to treating glioblastoma, a highly aggressive and difficult-to-treat form of brain cancer. The trial is investigating innovative treatment methods that aim to deliver better outcomes for glioblastoma patients. As part of this critical clinical trial, patients at North Shore University Hospital will have access to cutting-edge therapies under the guidance of leading neurosurgeons like Dr. Schulder.

How to Enroll in the ReSPECT-GBM Clinical Trial

This clinical trial site is now enrolling patients who meet the eligibility criteria. If you or a loved one are interested in participating in the ReSPECT-GBM trial, please reach out to Dr. Schulder’s patient coordinator for more information.

For full details about the trial and how to get in touch with Dr. Schulder’s team, visit the official trial website:
ReSPECT-GBM Clinical Trial Information

Key Details of the ReSPECT-GBM Trial:

• Study Focus: Investigating innovative therapies for glioblastoma (GBM).
• Site Location: North Shore University Hospital, Northwell Health, New York.
• Principal Investigator: Michael Schulder, M.D., Professor, Neurosurgery, Northwell Health.
• Current Enrollment Status: Now enrolling patients!

Stay Updated on ReSPECT-GBM and Clinical Trials

If you’re looking for more information on clinical trials for glioblastoma or other brain cancer treatments, be sure to follow us for the latest news and updates on the ReSPECT-GBM trial.

🔔 Sign up for our newsletter or follow us on social media to stay informed on new trial sites, updates, and advancements in neuro-oncology research.